TN
Highly rated in
1
conditions
Highly rated in
1
conditions

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

About Dr. Toshihiko Nakamura

Toshihiko Nakamura is in Musashino, Japan. Dr. Nakamura is highly rated in 1 condition, according to our data. Their top areas of expertise are Leukemoid Reaction, Infant Respiratory Distress Syndrome, Noma, and Newborn Transient Tachypnea.

Their clinical research consists of co-authoring 14 peer reviewed articles in the past 15 years.

Areas of Expertise

Many doctors have expertise treating multiple conditions. MediFind uses a variety of data sources to determine what conditions a doctor treats and their level of experience.

Locations
  Musashino, JP
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Keio University School Of Medicine
 
Tokyo, JP 16085
 12.1 km
Tsutomu Takeuchi is in Tokyo, Japan. They have been an author on 504 peer reviewed articles and participated in 6 clinical trials in the past 15 years.
Highly rated in
0
conditions
University Of Tokyo
 
Tokyo, JP 
 12.1 km
Masaomi Nangaku is in Tokyo, Japan. They have been an author on 445 peer reviewed articles in the past 15 years.
Highly rated in
0
conditions
Musashino Red Cross Hospital
 
Musashino, JP 
 0.1 km
Namiki Izumi is in Musashino, Japan. They have been an author on 284 peer reviewed articles and participated in 1 clinical trial in the past 15 years.